Hap Trading, LLC Editas Medicine, Inc. Call Options Transaction History

Hap Trading, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$8.32 - $13.21 $74,048 - $117,569	8,900 Added 55.97%	24,800 $5,000
Q3 2022 Nov 14, 2022	SELL	$12.16 - $19.42 $85,120 - $135,940	-7,000 Reduced 30.57%	15,900 $5,000
Q2 2022 Aug 12, 2022	BUY	$9.99 - $21.35 $48,951 - $104,615	4,900 Added 27.22%	22,900 $9,000
Q1 2022 May 12, 2022	SELL	$14.08 - $27.63 $99,968 - $196,173	-7,100 Reduced 28.29%	18,000 $21,000
Q4 2021 Feb 14, 2022	SELL	$26.55 - $40.57 $161,955 - $247,477	-6,100 Reduced 19.55%	25,100 $20,000
Q3 2021 Nov 10, 2021	SELL	$39.27 - $72.94 $1.11 Million - $2.06 Million	-28,200 Reduced 47.47%	31,200 $87,000
Q2 2021 Aug 11, 2021	SELL	$31.29 - $56.64 $391,125 - $708,000	-12,500 Reduced 17.39%	59,400 $768,000
Q1 2021 May 14, 2021	BUY	$39.71 - $90.58 $1.62 Million - $3.69 Million	40,700 Added 130.45%	71,900 $112,000
Q4 2020 Feb 16, 2021	SELL	$27.07 - $84.35 $4.26 Million - $13.3 Million	-157,400 Reduced 83.46%	31,200 $808,000
Q2 2020 Aug 10, 2020	BUY	$18.5 - $34.34 $3 Million - $5.56 Million	161,900 Added 606.37%	188,600 $136,000
Q1 2020 May 08, 2020	BUY	$14.88 - $32.78 $14,880 - $32,780	1,000 Added 3.89%	26,700 $32,000
Q4 2019 Feb 11, 2020	BUY	$19.49 - $32.63 $296,248 - $495,976	15,200 Added 144.76%	25,700 $68,000
Q1 2019 May 10, 2019	BUY	$19.43 - $26.41 $204,015 - $277,305	10,500 New	10,500 $25,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.